Cargando…
Circulating TP73‐AS1 and CRNDE serve as diagnostic and prognostic biomarkers for non‐small cell lung cancer
BACKGROUND: Circulating long noncoding RNAs (lncRNAs) are considered a new class of biomarkers for the diagnosis and prognosis of various malignancies. We aimed to identify circulating lncRNAs as biomarkers for the diagnosis and prognosis of non‐small cell lung cancer (NSCLC). METHODS: The expressio...
Autores principales: | Yuan, Rong‐Xia, Dai, Chun‐Hua, Chen, Ping, Lv, Meng‐Jia, Shu, Yang, Wang, Zhi‐Peng, Xu, Ya‐Ping, Li, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883423/ https://www.ncbi.nlm.nih.gov/pubmed/35871358 http://dx.doi.org/10.1002/cam4.5013 |
Ejemplares similares
-
Long non-coding RNA TP73-AS1 is a potential immune related prognostic biomarker for glioma
por: Zhang, Bo, et al.
Publicado: (2021) -
Serum exosomal long noncoding RNA CRNDE as a prognostic biomarker for hepatocellular carcinoma
por: Wang, Ting, et al.
Publicado: (2021) -
TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2017) -
TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2022) -
TP73 is a credible biomarker for predicting clinical progression and prognosis in cervical cancer patients
por: Ye, Hui, et al.
Publicado: (2019)